Bronchobos syrup 125 mg / 5 ml fl. 200ml

Release form

Syrup 2.5% in the form of a transparent slightly viscous liquid from pink to red, with a raspberry scent.

Packaging

Bottle 200 ml.

pharmachologic effect

Mucolytic drug.

The action of the drug is due to the activation of sialic transferase - an enzyme of the goblet cells of the bronchial mucosa.

Normalizes the quantitative ratio of acidic and neutral sialomucins of bronchial secretions, restores the viscosity and elasticity of mucus.

Promotes regeneration of the mucous membrane, normalizes its structure, activates the activity of the ciliated epithelium.

Restores the secretion of immunologically active IgA (specific protection) and the amount of sulfhydryl groups of mucus components (non-specific protection), improves mucociliary clearance.

Indications

acute and chronic bronchopulmonary diseases, accompanied by a violation

the formation and removal of mucus

inflammatory diseases of the middle ear

inflammatory diseases of the paranasal sinuses

preparation of the patient for bronchoscopy or bronchography.

Contraindications

peptic ulcer of the stomach and duodenum in the acute phase

acute glomerulonephritis

acute cystitis

children under 2 years old

pregnancy

lactation (breastfeeding)

hypersensitivity to drug components.

Application during pregnancy and lactation

use during pregnancy and lactation is contraindicated.

special instructions

The alcohol content in the preparation is 125 mg / 5 ml, i.e.

125 mg alcohol per scoop.

The effect of the drug on the ability to drive vehicles and perform work requiring increased concentration of attention and speed of psychomotor reactions.

Violation of the speed of psychomotor reactions associated with the presence of alcohol in the drug can be dangerous when driving a car or working on machines.

Structure

5 ml of syrup contains:

Active ingredient: carbocisteine ​​250 mg

Excipients: glycerol - 135 mg

ethanol 96% - 125 mg

sodium hydroxide - 61 mg

carmellose sodium - 20 mg

citric acid monohydrate - 10 mg

methyl parahydroxybenzoate - 9 mg

sodium saccharinate - 5 mg

propyl parahydroxybenzoate - 1 mg

raspberry flavor - 0.7 mg

azorubin CI 14720 (E122) - 0.05 mg

purified water - up to 5 ml.

Method of administration and dosage

Inside.

For the dosage of the syrup, a 5 ml measuring spoon is used, graduated to 2.5 ml.

1 scoop of 5% syrup (5 ml) = 250 mg carbocisteine ​​1 scoop of 2.5% syrup (5 ml) = 125 mg carbocysteine.

Adults - 15 ml (3 scoops) of 5% syrup 3 times a day.

Children aged 3–6 years - 5 ml (1 measuring spoon) 2.5% syrup 2–4 times a day.

Children over 6 years old - 5-10 ml (1-2 measuring spoons) 2.5% syrup 3 times a day.

Side effects

From the gastrointestinal tract: sometimes there is nausea, vomiting, diarrhea and epigastric pain, gastrointestinal bleeding.

Hypersensitivity reaction: there have been isolated cases of allergic reactions (itching, urticaria, exanthema, angioedema).

Others: dizziness, weakness, malaise.

In patients with bronchial asthma and elderly patients, airway obstruction may occur.

Drug interactions

Increases the effectiveness of glucocorticoid (mutually) and antibacterial therapy of infectious and inflammatory diseases of the upper and lower respiratory tract.

Potentiates the bronchodilator effect of theophylline.

The activity of carbocisteine ​​is weakened by antitussives and atropine-like drugs.

Due to the alcohol content, Bronchobos is prescribed with caution with the following drugs: drugs that cause adverse reactions (fever, redness, vomiting, tachycardia), when taken simultaneously with alcoholic beverages: disulfiram, cefamandol, cefoperazone, latamoxef (cephalosporin antibiotics), chloramphenicol antibes

Name ENG

BRONCHOBOS

Clinical and pharmacological group

Mucolytic drug

ATX code

Carbocisteine

Dosage

125mg / 5ml x 200ml

Structure

5 ml of syrup contains:.

Active ingredient: carbocisteine ​​250 mg

Excipients: glycerol - 135 mg

ethanol 96% - 125 mg

sodium hydroxide - 61 mg

carmellose sodium - 20 mg

citric acid monohydrate - 10 mg methyl parahydroxybenzoate - 9 mg

sodium saccharinate - 5 mg

propyl parahydroxybenzoate - 1 mg

raspberry flavor - 0.7 mg

azorubin CI 14720 (E122) - 0.05 mg

purified water - up to 5 ml.

Indications

acute and chronic bronchopulmonary diseases, accompanied by a violation of the formation and excretion of mucus (tracheitis, bronchitis, tracheobronchitis, bronchial asthma, bronchiectasis)

inflammatory diseases of the middle ear and paranasal sinuses (rhinitis, otitis media, sinusitis)

preparation of the patient for bronchoscopy or bronchography.

Contraindications

hypersensitivity to carbocisteine ​​and other components of the drug

peptic ulcer of the stomach and duodenum in the acute phase

chronic glomerulonephritis in the acute phase

cystitis

liver disease (for taking syrup)

alcoholism (for taking syrup)

epilepsy (for taking syrup)

brain injury or disease (for taking syrup)

pregnancy

lactation (breastfeeding)

children's age up to 3 years (for taking syrup 2.5%)

children under 15 years of age (for taking capsules and syrup 5%).

With caution: with chronic glomerulonephritis (in history), gastric ulcer and duodenal ulcer (in history), in II-III trimesters of pregnancy and during breastfeeding.

INN / Active ingredient

carbocisteine

Storage conditions and periods

At a temperature not higher than 30 degrees.

(do not freeze).

Expiration date: 3 years

Specifications

Category

Cough

,

Thinning phlegm

,

Expectorants

Scope of the drug

Respiratory system

Release form

Syrup

Manufacturer country

Bosnia and Herzegovina

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

2 years old

Vacation conditions

Without recipe

Brand name

Bosnalek +

Components

measuring spoon

The amount of the dosage form in the primary package

200 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Expectorant mucolytic agent

Anatomical and therapeutic characteristics

R05CB03 Carbocisteine

Dosage form

Syrup

The target audience

Children

Expiration date in days

1095

Dosage (volume) of the substance in the preparation

5 ml of syrup contains: active substance: carbocisteine ​​250 mg

Package weight, g

370

Mode of application

:

Inside.

< br> To dose the syrup, a 5 ml measuring spoon is used, graduated to 2.5 ml.

1 scoop of 5% syrup (5 ml) = 250 mg carbocisteine ​​1 scoop of 2.5% syrup (5 ml) = 125 mg carbocysteine.

< br> Adults - 15 ml (3 scoops) of 5% syrup 3 times a day.

< br> Children aged 3–6 years - 5 ml (1 measuring spoon) 2.5% syrup 2–4 times a day.

Children over 6 years old - 5-10 ml (1-2 measuring spoons) 2.5% syrup 3 times a day.

Information on technical characteristics, delivery set, country of manufacture